Resection improves survival rate in advanced melanoma cases

04/16/2013 | SkinAndAllergyNews.com

Patients with advanced melanoma treated with surgical resection along with the drug ipilimumab had a 5-year melanoma-specific survival rate of 51% and a median overall survival duration of 60 months, according to researchers at the John Wayne Cancer Institute in Santa Monica, Calif. A 2012 study found a 7% survival rate for advanced melanoma patients treated with systemic medical therapy alone.

View Full Article in:

SkinAndAllergyNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA